Manuela Gambella, Alberto Rocci, Roberto Passera, Francesca Gay, Paola Omedè, Claudia Crippa, Paolo Corradini, Alessandra Romano, Davide Rossi, Marco Ladetto, Mario Boccadoro, Antonio Palumbo. High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib. haematol [Internet]. 2014Feb.4 [cited 2024Nov.22];99(2):e14-e16. Available from: https://haematologica.org/article/view/6945